PRIMARY STUDY

A meta-analysis of negative symptoms in dual diagnosis schizophrenia

Key Findings:  This meta-analysis indicates that schizophrenia patients with a concurrent substance use disorder exhibit fewer negative symptoms compared to those who are abstinent.

Type of Study:  Clinical Meta-analysis

Study Sample Size:  1135

Study Result:  Positive

Research Location(s):  Canada

Year of Pub:  2006


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Not Applicable




Citation:  Potvin S, et al. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med. 2006; 36:431-40. doi: 10.1017/S003329170500574X

Authors:  Potvin S, Sepehry AA, Stip E